Literature DB >> 8616570

Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy.

L Huang1, L M Schnapp, J F Gruden, P C Hopewell, J D Stansell.   

Abstract

Kaposi's sarcoma (KS) is the most common neoplasm in persons infected with the human immunodeficiency virus (HIV). However, information about the presenting features of pulmonary KS is limited. To describe the clinical, laboratory, and radiographic features of pulmonary KS, medical records and chest radiographs of 168 patients with pulmonary KS diagnosed by bronchoscopy during a 7-yr period were reviewed. All of the patients were HIV-seropositive males, of whom 95% identified homosexual or bisexual sex as a risk factor for HIV infection. The median CD4 lymphocyte count was 19 cells/microliter. The most common symptoms were cough, dyspnea, and fever. Patients with a concurrent opportunistic pneumonia had a higher median serum lactate dehydrogenase (LDH) concentration than did those with pulmonary KS alone (p<0.001). The most common chest radiograph findings were bronchial-wall thickening, nodules, Kerley B lines, and pleural effusions. The presence of granular opacities or cystic spaces usually indicated concomitant Pneumocystitis carinii pneumonia (p < 0.001). Twenty-six patients (15.5%, 95% CI = 10.2% to 20.8%) had pulmonary KS in the absence of mucocutaneous involvement. The presentation of pulmonary KS is characterized by symptoms that cannot be distinguished from those of a superimposed infection. An elevated serum LDH concentration or a chest radiograph with granular opacities or cystic spaces should raise the suspicion of concurrent opportunistic pneumonia. The diagnosis of pulmonary KS should be considered in an HIV-infected homosexual or bisexual male with respiratory symptoms even in the absence of mucocutaneous lesions.

Entities:  

Mesh:

Year:  1996        PMID: 8616570     DOI: 10.1164/ajrccm.153.4.8616570

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

Review 1.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

2.  Ward round: Chronic respiratory symptoms with no response to tuberculosis treatment in a 35 year old HIV positive man.

Authors:  Ag Jones; J Bates; M Molyneux
Journal:  Malawi Med J       Date:  2007-06       Impact factor: 0.875

3.  Severe Kaposi Sarcoma in an Urban Public Hospital.

Authors:  Shirin Elisha Kasturia; Clifford Gunthel; Cheng Zeng; Minh Ly Nguyen
Journal:  AIDS Res Hum Retroviruses       Date:  2017-01-31       Impact factor: 2.205

4.  World AIDS Day: 40 years of an evolving pulmonary landscape.

Authors:  Kristina Crothers; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-11-10       Impact factor: 5.464

Review 5.  Evaluation of respiratory disease.

Authors:  Sofya Tokman; Laurence Huang
Journal:  Clin Chest Med       Date:  2013-04-15       Impact factor: 2.878

Review 6.  Human immunodeficiency virus-associated lung malignancies.

Authors:  Allison A Lambert; Christian A Merlo; Gregory D Kirk
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

7.  Pulmonary Kaposi sarcoma and disseminated Mycobacterium genavense infection in an HIV-infected patient.

Authors:  Cindy Tribuna; Cristina Ângela; Isabel Eira; Alexandre Carvalho
Journal:  BMJ Case Rep       Date:  2015-10-08

Review 8.  Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology.

Authors:  Taisa Davaus Gasparetto; Edson Marchiori; Sílvia Lourenço; Gláucia Zanetti; Alberto Domingues Vianna; Alair A S M D Santos; Luiz Felipe Nobre
Journal:  Orphanet J Rare Dis       Date:  2009-07-14       Impact factor: 4.123

9.  Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.

Authors:  Francesca Cainelli; Alfredo Vallone
Journal:  Biologics       Date:  2009-09-15

Review 10.  Noninfectious pulmonary complications of human immunodeficiency virus infection.

Authors:  Bashar Staitieh; David M Guidot
Journal:  Am J Med Sci       Date:  2014-12       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.